DE69519933D1 - Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen - Google Patents

Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen

Info

Publication number
DE69519933D1
DE69519933D1 DE69519933T DE69519933T DE69519933D1 DE 69519933 D1 DE69519933 D1 DE 69519933D1 DE 69519933 T DE69519933 T DE 69519933T DE 69519933 T DE69519933 T DE 69519933T DE 69519933 D1 DE69519933 D1 DE 69519933D1
Authority
DE
Germany
Prior art keywords
stage
prostaglandinanaloga
birth
oral
construction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69519933T
Other languages
English (en)
Other versions
DE69519933T2 (de
Inventor
Hazem El-Refaey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EL-REFAEY, HAZEM, DR., LONDON, GB
Original Assignee
University College London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London filed Critical University College London
Application granted granted Critical
Publication of DE69519933D1 publication Critical patent/DE69519933D1/de
Publication of DE69519933T2 publication Critical patent/DE69519933T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
DE69519933T 1994-09-27 1995-09-26 Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen Expired - Lifetime DE69519933T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9419566A GB9419566D0 (en) 1994-09-27 1994-09-27 Oral prostagladins for the routine management of the third stage of labour
PCT/GB1995/002277 WO1996009825A1 (en) 1994-09-27 1995-09-26 Prostagladin analogues by the oral or vaginal route for the routine management of the third stage of labour

Publications (2)

Publication Number Publication Date
DE69519933D1 true DE69519933D1 (de) 2001-02-22
DE69519933T2 DE69519933T2 (de) 2001-09-06

Family

ID=10762026

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69519933T Expired - Lifetime DE69519933T2 (de) 1994-09-27 1995-09-26 Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen

Country Status (11)

Country Link
US (1) US6664290B1 (de)
EP (1) EP0784475B1 (de)
AT (1) ATE198707T1 (de)
AU (1) AU3530095A (de)
DE (1) DE69519933T2 (de)
DK (1) DK0784475T3 (de)
ES (1) ES2154348T3 (de)
GB (1) GB9419566D0 (de)
GR (1) GR3035389T3 (de)
PT (1) PT784475E (de)
WO (1) WO1996009825A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1003199B (el) 1998-08-14 1999-09-01 Χρηση της μισοπροστολης ή και της μισοπροστολης οξυ για την παρασκευη φαρμακευτικου προιοντος για τη θεραπευτικη αντιμετωπιση της σεξουαλικης δυσλειτουργιας στις γυναικες
JP2002529204A (ja) 1998-11-13 2002-09-10 エラン・フアルマ・インターナシヨナル・リミテツド 薬品を給送するシステム及び方法
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) * 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006133048A2 (en) * 2005-06-03 2006-12-14 Duramed Pharmaceuticals, Inc. Pharmaceutical compositions comprising prostanoid-receptor agonists and methods of making and using the same
US8148560B2 (en) * 2005-09-23 2012-04-03 Teva Women's Health, Inc. Vaginal tablets comprising misoprostol and methods of making and using the same
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CN102580057B (zh) * 2012-03-14 2014-04-30 南京先宇科技有限公司 含有麦角新碱与缩宫素类似物的药物组合物及制备方法
CN103340837B (zh) * 2013-07-08 2018-04-27 天津市聚星康华医药科技有限公司 一种米索前列醇阴道泡腾片及其制备方法
US20160008310A1 (en) 2014-07-11 2016-01-14 Azanta A/S Misoprostol dispersible tablet
TN2017000003A1 (en) * 2014-07-11 2018-07-04 Azanta Danmark As Misoprostol dispersible tablet.

Also Published As

Publication number Publication date
ATE198707T1 (de) 2001-02-15
GB9419566D0 (en) 1994-11-16
WO1996009825A1 (en) 1996-04-04
PT784475E (pt) 2001-06-29
US6664290B1 (en) 2003-12-16
EP0784475B1 (de) 2001-01-17
DE69519933T2 (de) 2001-09-06
EP0784475A1 (de) 1997-07-23
DK0784475T3 (da) 2001-04-02
AU3530095A (en) 1996-04-19
GR3035389T3 (en) 2001-05-31
ES2154348T3 (es) 2001-04-01

Similar Documents

Publication Publication Date Title
Pedersen Decadronphosphate® in the relief of complaints after third molar surgery: A double-blind, controlled trial with bilateral oral surgery
DE69519933T2 (de) Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen
DE69021214T2 (de) Orale zusammensetzung für die behandlung intestinaler entzündlicher krankheiten.
BR0211062A (pt) Combinações para o tratamento de distúrbios inflamatórios
ES2172592T3 (es) Agente antagonista de progesterona y agente gestageno para el tratamiento de la endometriosis y del liomioma uterino.
NO990934D0 (no) Anvendelse av arakidonsyre og/eller dokosaheksansyre for fremstilling av et medikament for behandling av dyspraksi
IT1282736B1 (it) Uso di derivati del p-amminofenolo per preparare composizioni farmaceutiche utili nel trattamento di malattie neurodegenerative
ITRM920900A1 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
DE69426471T2 (de) Verwendung von Sulodexid und von Arzneimitteln, die dieses enthalten, zur Behandlung der diabetischen Nephropathie
SE9902597D0 (sv) New use
EG17992A (en) Preparation of a medicament for arthritis and theumatism
HUP0303795A2 (hu) Aromatáz inhibitorok alkalmazása a fogamzás elősegítésének fokozására alkalmas gyógyszerkészítmény előállítására
DE69815277T2 (de) Nimelulide enthaltendes pharmazeutisches präparat zur oralen verabreichung
AQ et al. Application of Mixture of 3% Citric Acid and 2% Lignocaine Jelly for Treatment of Recurrent Ulcers of the Tongue-A Rare Case Study
SU839543A1 (ru) Способ лечени больных очаговымииНфЕКци Ми
UA37750A (uk) Спосіб лікування запальних захворювань пародонту у вагітних жінок
RU2001129661A (ru) Способ лечения воспалительных заболеваний пародонта у женщин в перименопаузе
MD1715F1 (en) Method of prophylaxis and treatment of the precocious hypogalactia
FR2762214B1 (fr) Utilisation de la mizolastine pour la preparation d'un medicament destine au traitement de l'inflammation
UA37738A (uk) Спосіб профілактики та лікування ускладнень гестагенної терапії та контрацепції
MD1296F1 (en) The Nicolau method of treatment of the lichen planus
UA38912A (uk) Спосіб профілактики та лікування фетоплацентарної недостатності у вагітних жінок з внутрішньоматковою загибеллю плода в анамнезі
UA37370A (uk) Спосіб прогнозування ефективності монотерапії антагоністами кальцію під час лікування гіпертонічної хвороби
UA36679A (uk) Спосіб комплексного лікування гострого пієлонефриту породіль
UA29155A (uk) Спосіб лікування загрози передчасних пологів у жінокнаркоманок

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee
8328 Change in the person/name/address of the agent

Representative=s name: MUELLER - HOFFMANN & PARTNER PATENTANWAELTE, 81667 M

8370 Indication related to discontinuation of the patent is to be deleted
8327 Change in the person/name/address of the patent owner

Owner name: EL-REFAEY, HAZEM, DR., LONDON, GB